Position history for Boston Trust Walden Corp's holdings in GLOBUS MED INC
Boston Trust Walden Corp holds 1.4M shares of GMED (GLOBUS MED INC), worth $119.4M as of 2025-Q4. The position was increased (++15.4% shares). GMED represents 0.9% of Boston Trust Walden Corp's portfolio.
Current Value
$119.4M
Current Shares
1.4M
Total Value Change
+$68.2M
Total Shares Change
+619,858
Other major holders of GMED: UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC
Increased |
| 1.4M |
+15.4% |
| $119.4M |
| 0.9% |
| $87.91 |
49 |
| 2025-Q3 | New | 1.2M | - | $67.9M | 0.5% | $56.42 | 49 |
| 2025-Q1 | Exited | 0 | -100.0% | $0 | 0.0% | $72.55 | 0 |
| 2024-Q4 | Decreased | 619,652 | -15.1% | $51.3M | 0.4% | $82.67 | 0 |
| 2024-Q3 | Decreased | 729,924 | -2.4% | $52.2M | 0.4% | $70.61 | 0 |
| 2024-Q2 | Decreased | 748,129 | -0.1% | $51.2M | 0.4% | $68.49 | 0 |